Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | SVP HR Public Affairs & Philan | March 06, 2012 | March 09, 2012 |
| Teligent, Inc.TLGT · Entity 134764 | Director | July 21, 2021 | July 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date March 06, 2012 · Filed March 09, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 142,142 |
Ending reported balance
After 2012-03-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2012-03-06 · Exercise / conversion · Acquired 28,073 · Balance 149,037 F1: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Row 2 · 2012-03-06 · Exercise / conversion · Acquired 4,257 · Balance 153,294 F2: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Row 3 · 2012-03-06 · Tax withholding · Disposed 1,683 · Balance 151,611 F3: Shares withheld for payment of taxes upon vesting of restricted stock units. Row 4 · 2012-03-06 · Tax withholding · Disposed 9,469 · Balance 142,142 F4: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2016-03-06 | Direct | 10,593 |
Reported balance
After 2012-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2012-03-06 · Grant · Acquired 10,593 · Balance 10,593 F5: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 36,854.93 |
Reported balance
After 2012-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2012-03-06 · Grant · Acquired 10,010 · Balance 36,854.93 F7: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 46,643.93 |
Reported balance
After 2012-03-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2012-03-06 · Grant · Acquired 9,789 · Balance 46,643.93 F10: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F11: Represents performance shares earned under the 2010-2012 Long Term Performance Award. F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 47,477.5823 |
Reported balance
After 2012-03-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2012-03-06 · Other · Acquired 833.6523 · Balance 47,477.5823 F12: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F13: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 19,404.5823 |
Reported balance
After 2012-03-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2012-03-06 · Exercise / conversion · Disposed 28,073 · Balance 19,404.5823 F7: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F14: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2014-03-31 | Direct | 8,975 |
Reported balance
After 2012-03-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-03-06 · Grant · Acquired 8,975 · Balance 8,975 F15: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F16: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2014-03-31 | Direct | 9,378 |
Reported balance
After 2012-03-06 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-03-06 · Other · Acquired 403 · Balance 9,378 F17: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F18: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2012-03-06 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-03-06 · Exercise / conversion · Disposed 4,257 · Balance 0 F19: Each restricted stock unit converts into one share of common stock upon vesting. F2: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award.
F2: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested.
F3: Shares withheld for payment of taxes upon vesting of restricted stock units.
F4: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award.
F5: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
F6: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.
F7: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.
F8: Represents performance shares earned under the 2009-2011 Long-Term Performance Award.
F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards.
F10: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.
F11: Represents performance shares earned under the 2010-2012 Long Term Performance Award.
F12: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.
F13: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award.
F14: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only.
F15: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.
F16: Represents performance shares earned under the 2011-2013 Long-Term Performance Award.
F17: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.
F18: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award.
F19: Each restricted stock unit converts into one share of common stock upon vesting.
Teligent, Inc.
Report date July 21, 2021 · Filed July 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 150,000 |
Reported balance
After 2021-07-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-07-21 · Grant · Acquired 150,000 · Balance 150,000 F1: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock F3: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50. F2: The shares underlying the derivative securities shall vest fully on the first anniversary of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock
F2: The shares underlying the derivative securities shall vest fully on the first anniversary of grant.
F3: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 9,518 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007216 · doc4.xml · derivative · entry 6 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,798 Underlying: Common Stock, $0.10 par value · 9,518 shares Expires not disclosed F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · shares: Consists of performance shares earned under the 2009-2011 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 14,549 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007216 · doc4.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,280 Underlying: Common Stock, $0.10 par value · 14,549 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F7 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F6 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F6 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 13,979 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007216 · doc4.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,979 Underlying: Common Stock, $0.10 par value · 13,979 shares Expires not disclosed F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company?s common stock on the vesting date and the nine trading days immediately preceding the vesting date. F5 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. F5 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 6,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007216 · doc4.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,336 F2 · shares: Withheld for the payment of taxes upon payout of shares under a Long-Term Performance Award. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 20,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007216 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| March 01, 2010 Filed Mar 3, 2010 21:25 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 430 | $24.57 | $10,565.10 |
DisclosureSEC source: 0001225208-10-006842 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,601 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 25, 2010 Filed Mar 1, 2010 16:55 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 10,752 | $24.35 | $261,811.20 |
DisclosureSEC source: 0001225208-10-006204 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,031 Read SEC document |
| December 04, 2009 Filed Dec 8, 2009 22:46 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,635 | $25.14 | $66,243.90 |
DisclosureSEC source: 0001225208-09-024192 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,783 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 995 | $18.35 | $18,258.25 |
DisclosureSEC source: 0001225208-09-006762 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,192 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 8,880 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-006373 · doc4.xml · derivative · entry 2 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,880 Underlying: Common Stock, $0.10 par value · 8,880 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 104,949 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-09-006373 · doc4.xml · derivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,949 Underlying: Common Stock, $0.10 par value · 104,949 shares Expires 2019-03-02 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 02, 2009 Filed Mar 3, 2009 22:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 547 | $17.74 | $9,703.78 |
DisclosureSEC source: 0001225208-09-005826 · doc4.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,187 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2009 Filed Mar 3, 2009 22:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 431 | $18.41 | $7,934.71 |
DisclosureSEC source: 0001225208-09-005826 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,734 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 7,752 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004532 · doc4.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,731 Underlying: Common Stock, $0.10 par value · 7,752 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F6 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F5 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 15,484 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004532 · doc4.xml · derivative · entry 3 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,979 Underlying: Common Stock, $0.10 par value · 15,484 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. F4 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F3 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. F3 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantCommon Stock, $0.10 par value | 14,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004532 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,165 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| February 19, 2009 Filed Mar 24, 2009 19:43 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 4,774 | $20.51 | $97,914.74 |
DisclosureSEC source: 0001225208-09-007613 · doc4a.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · Pres Emerging Mkts & Asia-Pac 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,391 F1 · kind: This Form 4 is being amended to reflect the shares withheld for taxes upon the distribution of a performance share award. F2 · shares: Shares withheld for payment of taxes upon distribution of long-term performance award. F3 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| December 05, 2008 Filed Dec 9, 2008 21:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,969 | $21.23 | $41,801.87 |
DisclosureSEC source: 0001225208-08-019201 · doc4.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,671 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 7,981 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000095 · cel836.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,981 Underlying: Common Stock, $0.10 par value · 7,981 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F6 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F6 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 104,594 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0000014272-08-000095 · cel836.xml · derivative · entry 3 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,594 Underlying: Common Stock, $0.10 par value · 104,594 shares Expires 2018-03-03 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest 25% per year, on a cumulative basis, commencing one year after the grant date. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 788 | $22.14 | $17,446.32 |
DisclosureSEC source: 0000014272-08-000095 · cel836.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,640 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2008 Filed Feb 17, 2009 23:32 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 6,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-09-000011 · primary_doc.xml · derivative · entry 1 Celentano John E · CIK 0001346102 · SVP Strat & Productivity Trans 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,495 Underlying: Common Stock $0.10 par value · 6,495 shares Expires not disclosed F1 · derivative.exercise_price: (1) Each performance share converts into one share of common stock upon distribution during the first quarter of 2010. F1 · derivative.exercise_date: (1) Each performance share converts into one share of common stock upon distribution during the first quarter of 2010. F1 · derivative.expiration_date: (1) Each performance share converts into one share of common stock upon distribution during the first quarter of 2010. Read SEC document |
| March 02, 2008 Filed Mar 4, 2008 18:35 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 547 | $22.61 | $12,367.67 |
DisclosureSEC source: 0000014272-08-000073 · cel824.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,428 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2008 Filed Mar 4, 2008 18:35 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 431 | $22.61 | $9,744.91 |
DisclosureSEC source: 0000014272-08-000073 · cel824.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,975 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 20:05 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 788 | $31.56 | $24,869.28 |
DisclosureSEC source: 0000014272-07-000160 · cel738.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,406 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 15, 2007 Filed May 17, 2007 19:41 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 4,501 | $0.00 Strike: $28.90 | $0.00 |
DisclosureSEC source: 0000014272-07-000138 · cel712.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,501 shares Expires 2007-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently Exercisable. Read SEC document |
| May 15, 2007 Filed May 17, 2007 19:41 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 59 | $30.23 | $1,783.57 |
DisclosureSEC source: 0000014272-07-000138 · cel712.xml · nonDerivative · entry 3 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,194 F3 · shares: Shares withheld for payment of taxes upon exercise of stock option. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 15, 2007 Filed May 17, 2007 19:41 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 4,303 | $30.23 | $130,079.69 |
DisclosureSEC source: 0000014272-07-000138 · cel712.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,253 F2 · shares: Shares withheld for payment of exercise price. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 15, 2007 Filed May 17, 2007 19:41 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 4,501 | $28.90 | $130,078.90 |
DisclosureSEC source: 0000014272-07-000138 · cel712.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 11, 2007 Filed May 15, 2007 20:58 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 15,749 | $0.00 Strike: $28.90 | $0.00 |
DisclosureSEC source: 0000014272-07-000133 · cel709.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,501 Underlying: Common Stock, $0.10 par value · 15,749 shares Expires 2007-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently Exercisable. Read SEC document |
| May 11, 2007 Filed May 15, 2007 20:58 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 207 | $30.24 | $6,259.68 |
DisclosureSEC source: 0000014272-07-000133 · cel709.xml · nonDerivative · entry 3 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,055 F3 · shares: Shares withheld for payment of taxes upon exercise of stock option. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 11, 2007 Filed May 15, 2007 20:58 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 15,052 | $30.24 | $455,172.48 |
DisclosureSEC source: 0000014272-07-000133 · cel709.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,262 F2 · shares: Shares withheld for payment of exercise price. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 11, 2007 Filed May 15, 2007 20:58 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 15,749 | $28.90 | $455,146.10 |
DisclosureSEC source: 0000014272-07-000133 · cel709.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 12,770 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,770 Underlying: Common Stock, $0.10 par value · 12,770 shares Expires 2017-03-05 F6 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 51,090 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,090 Underlying: Common Stock, $0.10 par value · 51,090 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 433 | $27.01 | $11,695.33 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,565 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 1,465 | $27.01 | $39,569.65 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,998 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 12,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,770 Underlying: Common Stock, $0.10 par value · 12,770 shares Expires not disclosed F6 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F7 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 51,090 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,090 Underlying: Common Stock, $0.10 par value · 51,090 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 433 | $27.01 | $11,695.33 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,565 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 1,465 | $27.01 | $39,569.65 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,998 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 02, 2007 Filed Mar 6, 2007 19:53 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,341 | $26.42 | $35,429.22 |
DisclosureSEC source: 0000014272-07-000062 · cel664.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,533 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 22:08 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 640 | $28.80 | $18,432.00 |
DisclosureSEC source: 0000014272-07-000046 · cel656.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,874 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 19:38 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $24.74 | $0.00 |
DisclosureSEC source: 0000014272-06-000228 · cel630.xml · derivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock, $0.10 par value · 175,000 shares Expires 2016-11-30 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest one-third per year, on a cumulative basis, on the third, fourth, and fifth anniversaries of the grant date. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 18:41 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 788 | $25.77 | $20,306.76 |
DisclosureSEC source: 0000014272-06-000165 · cel579.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,514 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| May 30, 2006 Filed May 31, 2006 16:04 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | SaleCommon Stock, $0.10 par value | 500 | $24.91 | $12,455.00 |
DisclosureSEC source: 0000014272-06-000149 · cel568.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,302 Read SEC document |
| May 30, 2006 Filed May 31, 2006 16:04 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | SaleCommon Stock, $0.10 par value | 1,828 | $24.92 | $45,553.76 |
DisclosureSEC source: 0000014272-06-000149 · cel568.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,802 Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 42,200 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0000014272-06-000093 · cel527.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,200 Underlying: Common Stock, $0.10 par value · 42,200 shares Expires 2016-03-06 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 976 | $22.73 | $22,184.48 |
DisclosureSEC source: 0000014272-06-000093 · cel527.xml · nonDerivative · entry 3 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,630 F3 · shares: Shares withheld for payment of taxes. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 3,304 | $22.73 | $75,099.92 |
DisclosureSEC source: 0000014272-06-000093 · cel527.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,606 F2 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.